ProMIS Neurosciences enters up to $18M at-the-market equity offering with H.C. Wainwright

ProMIS Neurosciences Inc.

ATM agreement filed Aug 19, 2025; allows sale of up to $17,988,524 in common shares.
Agent H.C. Wainwright receives 3% commission on gross proceeds from any sales.
Sales commence only after SEC declares Registration Statement effective (filed Aug 13, 2025).
No minimum sales required; shares sold through Nasdaq at prevailing market prices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.